Radiotherapy issues in elderly breast cancer patients

Breast Care

Volumn 7, Issue 6, 2012, Pages 453-459

  Kunkler, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Breast cancer; Elderly; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; GERIATRIC PATIENT; HUMAN; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84879106350     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000345870     Document Type: Review

References (60)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Albrand G, Terret C: Early breast cancer in the elderly: assessment and management considerations. Drugs Aging 2008;25:35-45.
3. Cutuli B, De Lafontan B, Vitali E, Costa L, Aristei C, Marchal C, Quetin P, Fay R: Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: analysis of 927 cases. Crit Rev Oncol Hematol 2009;71:79-88.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
5. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM: The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31:100-110.
6. Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM Jr, Hwang YT, Mandelblatt JS; Outcomes and Preferences for Treatment in Older Women Nationwide Study Research Team: Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer 2002;94:2534-2541.
7. Steinfeld AD, Diamond JJ, Hanks GE, Coia LR, Kramer S: Patient age as a factor in radiotherapy. Data from the Patterns of Care study. J Am Geriatr Soc 1989;37:335-338.
8. Kantorowitz DA, Poulter CA, Sischy B, Paterson E, Sobel SH, Rubin P, Dvoretsky PA, Mishalak W, Doane KL: Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radio-therapy. Int J Radiat Oncol Biol Phys 1988;15:263-270.
9. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-726.
10. Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML: Breast cancer treatment guidelines in older patients. J Clin Oncol 2005;23:783-791.
11. Kiderlen M, Bastiaannet E, Walsh PM, Keating NL, Schrodi S, Engel J, van de Water W, Ess SM, van Eycken L, Miranda A, de Munck L, van de Velde CJ, de Craen AJ, Liefers GJ: Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat 2012;132:675-682.
12. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Breast Version 1,2005. Fort Washington, PA, National Comprehensive Cancer Network, 2005, p BINV2.
13. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS: Choice of cancer therapy varies with age of patient. JAMA 1986;255:3385-3390.
14. Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD: Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985;33:585-589.
15. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA 2001;285:885-892.
16. O'Connell JB, Maggard MA, Ko CY: Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol 2004;11:962-969.
17. Busch E, Kemeny M, Fremgen A, Osteen RT, Winchester DP, Clive RE: Patterns of breast cancer care in the elderly. Cancer 1996;78:101-111.
18. Du X, Freeman JL, Freeman DH, Syblik DA, Goodwin JS: Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol A Biol Sci Med Sci 1999;54:M474-M478.
19. Watts G: Why the exclusion of older people from clinical research must stop. BMJ 2012;344:e3445.
20. PREDICT: Increasing the participation of the elderly in clinical trials. Literature review 20008. www.predicteu.org/Reports/PREDICT-WP1-Report. pdf.
21. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
22. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effect of radiotherapy after breastconserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:1707-1716.
23. Giordano SH: Radiotherapy in older women with low-risk breast cancer: Why did practice not change? J Clin Oncol 2012;30:1577-1578.
24. Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, Goh TT, Lindley R, Cairns J: A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 2007;11:1-149, iii-iv.
25. Williams LJ, Kunkler IH, King CC, Jack W, van der Pol M: A randomised controlled trial of post-operative radiotherapy following breastconserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial. Health Technol Assess 2011;15:1-57.
26. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager JJ, Hoogenraad W, Collette L, Pierart M; European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-1387.
27. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Wárlámn-Rodenhuis CC, Pierart M, Collette L: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007;25:3259-3265.
28. Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, Reed M, Ciatto S, Voogd AC, Brain E, Cutuli BM, Terret C, Gosney M, Aapro M, Audisio R: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012;13:e148-e160.
29. Vaidya JS, Joseph DJ, Tobias JS: Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010;376:91-102.
30. Intra M, Luini A, Gatti G, Ciocca M, Gentilini OD, Viana AA, Chagas EM, Berrettini A, Schuh F, Scarpa D, Orecchia R, Veronesi U: Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery 2006;140:467-471.
31. Chen PY, Wallace M, Mitchell C, Grills I, Kestin L, Fowler A, Martinez A, Vicini F: Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2010;76:991-997.
32. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, Julian TB, Marks LB, Todor DA, Vicini FA, Whelan TJ, White J, Wo JY, Harris JR: Accelerated partial breast irradiation consensus statement from the American Society of Radiation Oncology (ASTRO). J Am Coll Surg 2009;209:269-277.
33. Polgár C, Van Limbergen E, Pötter R, Kovács G, Polo A, Lyczek J, Hildebrandt G, Niehoff P, Guinot JL, Guedea F, Johansson B, Ott OJ, Major T, Strnad V; GEC-ESTRO breast cancer working group: Patient selection for accelerated partial-breast irradiation (ABPI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010;94:264-273.
34. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR: The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-341.
35. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR: The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:1098-1107.
36. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bogen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C: Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-520.
37. National Institute for Clinical Excellence (NICE): Early and Locally Advanced Breast Cancer: Diagnosis and Treatment. London, NICE, 2009.
38. Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Ibbott GS, McCormick B, McQueen JR, Pierce LJ, Powell SN, Recht A, Taghian AG, Vicini FA, White JR, Haffty BG: Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;81:59-68.
39. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L; Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-977.
40. Hughes KS, Schnaper LA, Cirrincione C, Berry DA, McCormick B, Muss HB, Shank B, Hudis C, Winer EP, Smith BL: Lumpectomy plus tamoxifen with or without irradiation in women aged 70 or older with early breast cancer. J Clin Oncol 2010;28(suppl 15):507.
41. Smith IE, Ross GM: Breast radiotherapy after lumpectomy-no longer always necessary. N Eng J Med 2004;351:1021-1023.
42. Soulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, Gross CP: Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol 2012;30:1601-1607.
43. Ravdin PM, Siminoff IA, Harvey JA: Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 1998;16:515-521.
44. Rogers EM: Diffusion of Innovations, ed 4. New York, Free Plaza, 1995.
45. Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, García-Closas M, Caldas C, Pharoah PD, Huntsman D: Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010;7:e1000279.
46. Dawson SJ, Makretsov N, Blows FM, Driver KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG, McLean CA, Callagy G, Green AR, Ellis I, Gelmon K, Turashvili G, Leung S, Aparicio S, Huntsman D, Caldas C, Pharoah P: BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 2010;103:668-675.
47. Ali HR, Dawson SJ, Blows FM, Provenzano E, Leung S, Nielsen T, Pharoah PD, Caldas C: A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer. J Pathol 2012;226:97-107.
48. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S; METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012;486:346-352.
49. Kunkler I: PRIME II breast cancer trial. Clin Oncol 2004;16:447-448.
50. Tinterri C, Gatzemeier W, Zanini V, Regolo L, Pedrazzoli C, Rondini E, Amanti C, Gentile G, Taffurelli M, Fenaroli P, Tondini C, Sacchetto G, Sismondi P, Murgo R, Orlandi M, Cianchetti E, Andreoli C: Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast 2009;18:373-377.
51. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006;98:681-690.
52. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
53. Beadle BM, Woodward WA, Buchholz TA: The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 2011;21:26-34.
54. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen Hat: Postoperative radiotherapy in high-risk postmenopausal breastcancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-1648.
55. Smith BD, Haffty BG, Hurria A, Galusha DH, Gross CP: Postmastectomy radiation and survival in older women with cancer. J Clin Oncol 2006;24:4901-4907.
56. Truong PT, Lee J, Kader HA, Speers CH, Olivotto IA: Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 2005;41:1267-1277.
57. Poortmans P: Evidence based radiation oncology: breast cancer. Radiother Oncol 2007;84:84-101.
58. Marks LB, Zeng J, Prosnitz LR: One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol 2008; 26:2075-2077.
59. Russell NS, Kunkler IH, van Tienhoven G, Canney PA, Thomas J, Bartlett J, van de Vijver MJ, Belkacemi Y, Yarnold JR, Barrett-Lee PJ: Postmastectomy radiotherapy: Will the selective use of postmastectomy radiotherapy study end the debate? J Clin Oncol 2009;27:996-997.
60. Kunkler IH, Canney P, van Tienhoven G, Russell NS; MRC/EORTC (BIG 2-04) SUPREMO Trial Management Group: Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol 2008;20:31-34.